Search

4 results

Reset

Therapy studies

Bacteriophage Therapy of Difficult-to-treat Infections

Completed. Checked 2026-10-03. A retrospective, observational analysis of the first one hundred consecutive cases of bacteriophage therapy of difficult-to-treat infections, facilitated by a Belgian consortium. Bacteriophage Therapy of Diffi

Bacterial infections Bacteriophages Antibiotic resistance Observational study Retrospective analysis Difficult to treat infections
Therapy studies

Proof of Concept Study to Assess Safety and Efficacy of Phage Therapy in Hip or Knee Prosthetic Joint Infections Due to Staphylococcus Aureus Treated by DAIR.

Not yet recruiting. Checked 2026-10-03. Total joint replacements are effective for chronic pain but can lead to Prosthetic Joint Infections (PJI), primarily caused by Staphylococcus aureus and resistant to antibiotics. Standard treatment in

Prosthetic Joint Infection PJI Bacteriophages Phages DAIR Phage Therapy Antimicrobials
Therapy studies

Safety and Tolerability of NTR-101 in Patients With Acute Alcohol-Associated Hepatitis

Not yet recruiting. Checked 2026-10-03. The goal of this clinical trial is to learn about the safety and tolerability of NTR-101 in adult participants suffering from acute alcohol-associated hepatitis (AH). The drug is intended for use in

bacteriophages alcohol-associated hepatitis NTR-101 bacteriophage therapy
Therapy studies

Bacteriophages in Addition to Antibiotics for the Treatment of Patients With Infective Endocarditis

Recruiting. Checked 2026-10-03. Infective endocarditis (IE) is an endocardial lesion caused by bacterial and/or fungal infection that most commonly affects the heart valves and/or the endocardium around implanted intracardiac devices. In ge

infective endocarditis bacteriophages